Trials / Sponsors / DisperSol Technologies, LLC
DisperSol Technologies, LLC
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PK and Dose Escalation and Expansion Study of DST-2970 Prostate Cancer | Phase 1 | 2020-01-31 |
| Completed | Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Pati Thalassemia Major | Phase 2 | 2019-08-20 |